REOLYSIN
REO 020
Phase 2 mab completed
Quick answer
REOLYSIN for Metastatic Melanoma is a Phase 2 program (mab) at ONCOLYTICS BIOTECH INC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- ONCOLYTICS BIOTECH INC
- Indication
- Metastatic Melanoma
- Phase
- Phase 2
- Modality
- mab
- Status
- completed